Table 1

Demographic and clinical history data of patients with AD with higher (N = 463) and lower BPSD scores (N = 551).

AD + BPSD

AD - BPSD


Age (mean ± SD)

77.3 ± 6.7

77.1 ± 6.9


Gender (% men)

35.4%

34.8%


Years since AD symptoms (mean ± SD)

3.87 ± 2.32

3.89 ± 2.50


Years since AD diagnosis (mean ± SD)

1.32 ± 1.33

1.26 ± 1.19


Prior diagnosis of BPSD (before1 year)

42.7%

39.1%


Current treatment for AD

94.8%

95.6%


Behavioural symptoms (last year)

89.8%

89.7%


Tearfulness

36.1%

40.8%


Depression

49.9%

51.9%


Concentration

59.0%

59.7%


Cooperation

40.0%

42.5%


Delusions

42.1%

37.0%


Hallucinations

32.8%

28.5%


Pacing

31.5%

26.5%


Motor activity

35.2%

33.8%


Appetite change

29.8%

29.6%


Apathy

23.8%

24.0%


Anxiety

27.6%

24.5%


Agitation

25.5%

24.1%


Delirium

8.9%

6.9%


Extrapyramidal symptoms (last year)

53.8%

54.6%


Tremors

37.6%

38.3%


Rigidity

14.0%

14.3%


Hypokinesia

11.2%

9.8%


Postural instability

9.9%

8.3%


Fluctuating cognition

8.6%

7.6%


Psychotic breaks (last year)

18.4%

16.0%


N° breaks (mean ± SD)

2.43 ± 3.58

1.74 ± 1.68


Dementia severity: MMSE Severe

12.8%

15.1%


Moderate

46.5%

46.6%


Mild

40.7%

38.3%


AD + BPSD: patients with higher ADAS-Noncog scores. AD - BPSD: patients with lower ADAS-Noncog scores.

Fernández et al. BMC Neurology 2010 10:87   doi:10.1186/1471-2377-10-87

Open Data